Cargando…
KIF23 is a potential biomarker of diffuse large B cell lymphoma: Analysis based on bioinformatics and immunohistochemistry
Diffuse Large B Cell Lymphoma (DLBCL), the most common form of blood cancer. The genetic and clinical heterogeneity of DLBCL poses a major barrier to diagnosis and treatment. Hence, we aim to identify potential biomarkers for DLBCL. Differentially expressed genes were screened between DLBCL and the...
Autores principales: | Gong, Yuqi, Zhou, Lingna, Ding, Liya, Zhao, Jing, Wang, Zhe, Ren, Guoping, Zhang, Jing, Mao, Zhengrong, Zhou, Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276187/ https://www.ncbi.nlm.nih.gov/pubmed/35713434 http://dx.doi.org/10.1097/MD.0000000000029312 |
Ejemplares similares
-
NEK2 Promotes Cell Proliferation and Glycolysis by Regulating PKM2 Abundance via Phosphorylation in Diffuse Large B-Cell Lymphoma
por: Zhou, Lingna, et al.
Publicado: (2021) -
Identification of hub genes associated with the pathogenesis of diffuse large B-cell lymphoma subtype one characterized by host response via integrated bioinformatic analyses
por: Zhou, Lingna, et al.
Publicado: (2020) -
CCDC50, an essential driver involved in tumorigenesis, is a potential severity marker of diffuse large B cell lymphoma
por: Gong, Yuqi, et al.
Publicado: (2023) -
The expression and prognostic significance of Drp1 in lung cancer: A bioinformatics analysis and immunohistochemistry
por: Yu, Lingling, et al.
Publicado: (2019) -
Prognostic significance of KIF2A and KIF20A expression in human cancer: A systematic review and meta-analysis
por: Li, Xing, et al.
Publicado: (2019)